HIZENTRA human normal immunoglobulin 20% solution for subcutaneous injection 5 mL vial Australia - English - Department of Health (Therapeutic Goods Administration)

hizentra human normal immunoglobulin 20% solution for subcutaneous injection 5 ml vial

csl behring australia pty ltd - normal immunoglobulin, quantity: 1 g - injection, solution - excipient ingredients: water for injections; proline; polysorbate 80 - replacement therapy in adults and children in: - primary immunodeficiency disease (pid) and - symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment. immunomodulatory therapy in: - chronic inflammatory demyelinating polyneuropathy (cidp) as maintenance therapy after stabilisation with ivig.

HIZENTRA human normal immunoglobulin 20% solution for subcutaneous injection 10 mL vial Australia - English - Department of Health (Therapeutic Goods Administration)

hizentra human normal immunoglobulin 20% solution for subcutaneous injection 10 ml vial

csl behring australia pty ltd - normal immunoglobulin, quantity: 2 g - injection, solution - excipient ingredients: polysorbate 80; proline; water for injections - replacement therapy in adults and children in: - primary immunodeficiency disease (pid) and - symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment. immunomodulatory therapy in: - chronic inflammatory demyelinating polyneuropathy (cidp) as maintenance therapy after stabilisation with ivig.

HIZENTRA human normal immunoglobulin 20% solution for subcutaneous injection 50 mL vial Australia - English - Department of Health (Therapeutic Goods Administration)

hizentra human normal immunoglobulin 20% solution for subcutaneous injection 50 ml vial

csl behring australia pty ltd - normal immunoglobulin, quantity: 10 g - injection, solution - excipient ingredients: polysorbate 80; proline; water for injections - replacement therapy in adults and children in: - primary immunodeficiency disease (pid) and - symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment. immunomodulatory therapy in: - chronic inflammatory demyelinating polyneuropathy (cidp) as maintenance therapy after stabilisation with ivig.

HIZENTRA human normal immunoglobulin 20% solution for subcutaneous injection 20 mL vial Australia - English - Department of Health (Therapeutic Goods Administration)

hizentra human normal immunoglobulin 20% solution for subcutaneous injection 20 ml vial

csl behring australia pty ltd - normal immunoglobulin, quantity: 4 g - injection, solution - excipient ingredients: polysorbate 80; proline; water for injections - replacement therapy in adults and children in: - primary immunodeficiency disease (pid) and - symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment. immunomodulatory therapy in: - chronic inflammatory demyelinating polyneuropathy (cidp) as maintenance therapy after stabilisation with ivig.

ASPEN FENTANYL fentanyl (as citrate) 500 microgram/10 mL solution for injection Australia - English - Department of Health (Therapeutic Goods Administration)

aspen fentanyl fentanyl (as citrate) 500 microgram/10 ml solution for injection

aspen pharmacare australia pty ltd - fentanyl citrate, quantity: 785 microgram (equivalent: fentanyl, qty 500 microgram) - injection, solution - excipient ingredients: sodium chloride; water for injections - short duration analgesia during premedication, induction and maintenance of anaesthesia, and in the immediate postoperative period. opioid analgesic supplement to general and regional anaesthesia. combination with a neuroleptic as an anaesthetic premedication for the induction of anaesthesia, and as an adjunct in the maintanance of general and regional anaesthesia.

ASPEN FENTANYL fentanyl (as citrate) 100 microgram/2 mL solution for injection Australia - English - Department of Health (Therapeutic Goods Administration)

aspen fentanyl fentanyl (as citrate) 100 microgram/2 ml solution for injection

aspen pharmacare australia pty ltd - fentanyl citrate, quantity: 157 microgram (equivalent: fentanyl, qty 100 microgram) - injection, solution - excipient ingredients: sodium chloride; water for injections - short duration analgesia during premedication, induction and maintenance of anaesthesia, and in the immediate postoperative period. opioid analgesic supplement to general and regional anaesthesia. combination with a neuroleptic as an anaesthetic premedication for the induction of anaesthesia, and as an adjunct in the maintanance of general and regional anaesthesia.

ASPEN ADRENALINE INJECTION adrenaline (epinephrine) 1 mg/10 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

aspen adrenaline injection adrenaline (epinephrine) 1 mg/10 ml solution for injection ampoule

aspen pharmacare australia pty ltd - adrenaline (epinephrine), quantity: 1 mg - injection, solution - excipient ingredients: tartaric acid; sodium metabisulfite; sodium chloride; water for injections; dilute hydrochloric acid; sodium hydroxide - an adjunct in the management of cardiac arrest.

RHOPHYLAC 1500IU human anti-D immunoglobulin solution for injection syringe Australia - English - Department of Health (Therapeutic Goods Administration)

rhophylac 1500iu human anti-d immunoglobulin solution for injection syringe

csl behring australia pty ltd - anti-d rho immunoglobulin, quantity: 1500 iu - injection, solution - excipient ingredients: chloride; glycine; sodium; albumin - prevention of rh sensitisation in rh(d)-negative females at or below child-bearing age and treatment of rh(d)-negative persons after incompatible transfusions of rh(d)-positive blood or other products containing red blood cells.

DIABACT UBT urea[13C] 50 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

diabact ubt urea[13c] 50 mg tablet blister pack

medical diagnostics australasia pty ltd - urea(13c), quantity: 50 mg - tablet, uncoated - excipient ingredients: magnesium stearate; colloidal anhydrous silica; croscarmellose sodium; purified talc; microcrystalline cellulose; citric acid - this medicinal product is for diagnostic use only. diabact ubt is for in vivo diagnosis of gastroduodenal helicobacter pylori infection.

DIABACT UBT kit urea[13C] 50 mg tablet blister pack with other components Australia - English - Department of Health (Therapeutic Goods Administration)

diabact ubt kit urea[13c] 50 mg tablet blister pack with other components

medical diagnostics australasia pty ltd - urea(13c), quantity: 50 mg - tablet, uncoated - excipient ingredients: colloidal anhydrous silica; microcrystalline cellulose; citric acid; purified talc; croscarmellose sodium; magnesium stearate - this medicinal product is for diagnostic use only. diabact ubt is for in vivo diagnosis of gastroduodenal helicobacter pylori infection.